- €1.22bn
- €1.51bn
- €424.74m
- 87
- 23
- 91
- 78
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
Standards: | — | — | — | — | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 227 | 363 | 338 | 388 | 425 |
Cost of Revenue | |||||
Gross Profit | 138 | 246 | 212 | 198 | 228 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 182 | 244 | 256 | 359 | 377 |
Operating Profit | 45.7 | 119 | 82.3 | 29 | 48 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 43.7 | 106 | 89.8 | 34.6 | 18.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | 33.1 | 78.1 | 67.6 | 24.1 | 13.6 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 33.1 | 78.1 | 67.6 | 24.1 | 13.6 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 33.1 | 78.1 | 67.6 | 24.1 | 13.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.187 | 0.47 | 0.402 | 0.175 | 0.088 |
Dividends per Share |